NKG2D initiates caspase-mediated CD3zeta degradation and lymphocyte receptor impairments associated with human cancer and autoimmune disease.

Source:http://linkedlifedata.com/resource/pubmed/id/20926796

J. Immunol. 2010 Nov 15 185 10 5732-42

Download in:

View as

General Info

PMID
20926796